Table 1 Baseline characteristics stratified by the train or test cohort.
All patients (n = 260) | Train cohort (n = 169) | Test cohort (n = 91) | P value* | |
---|---|---|---|---|
Age, years | 58.9 ± 14.6 | 58.6 ± 14.5 | 59.4 ± 14.9 | 0.720 |
Male sex | 190 (73.1%) | 122 (72.2%) | 68 (74.7%) | 0.660 |
Height, cm | 165.6 ± 8.6 | 165.4 ± 8.5 | 165.8 ± 8.7 | 0.552 |
Weight, kg | 64.7 ± 13.8 | 64.2 ± 14.0 | 65.7 ± 12.8 | 0.289 |
BMI, kg/m2 | 23.5 ± 3.9 | 23.3 ± 3.9 | 23.8 ± 3.8 | 0.272 |
Hypertension | 121 (46.5%) | 78 (46.2%) | 43 (47.3%) | 0.865 |
Diabetes mellitus | 47 (18.1%) | 33 (19.5%) | 14 (15.4%) | 0.532 |
Dyslipidemia | 105 (40.4%) | 75 (44.4%) | 30 (33.3%) | 0.074 |
Chronic heart failure | 121 (46.5%) | 78 (46.2%) | 43 (47.3%) | 0.865 |
Coronary artery disease | 100 (38.4%) | 70 (41.4%) | 30 (33.0%) | 0.181 |
Pulmonary hypertension | 41 (15.8%) | 22 (13.0%) | 19 (20.9%) | 0.097 |
Arrhythmias | 37 (14.2%) | 14 (15.4%) | 23 (13.6%) | 0.696 |
Prescription of a β-blocker | 177 (68.1%) | 122 (72.2%) | 55 (60.4%) | 0.142 |
AF rhythm during CPX | 25 (9.6%) | 17 (8.8%) | 8 (10.1%) | 0.741 |